Or
Orbital Ther
Cambridge MAFounded 202120 employees
Private CapbiotechPrivateGenetic Medicine
Platform: tRNA
Market Cap
N/A
All Drugs
3
Clinical Trials
10
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Kemafutibatinib | ORB-4844 | Phase 3 | 4 | CD38 | DLBCL | ||
| Mirinaritide | ORB-7855 | Phase 2/3 | 2 | PD-L1 | ALL | ||
| ORB-4389 | ORB-4389 | Phase 3 | 4 | PRMT5 | PsASCLC |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (9)